Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13

• Kazimierz Groen,
• Fredrik H. Schjesvold,
• Bronno van der Holt,
• Mark-David Levin,
• Maarten R. Seefat,
• Markus Hansson,
• Maria B.L. Leys,
• Josien C. Regelink,
• Anders Waage,
• Damian Szatkowski,
• Per Axelsson,
• Trung Hieu Do,
• Asta Svirskaite,
• Ellen van der Spek,
• Einar Haukas,
• Dorota Knut-Bojanowska,
• Paula F. Ypma,
• Cecilie H. Blimark,
• Ulf-Henrik Mellqvist,
• Niels W.C.J. van de Donk,
• Pieter Sonneveld,
• Anja Klostergaard,
• Annette J. Vangsted,
• Niels Abildgaard,
• Sonja Zweegman

Affiliations

Kazimierz Groen

1 Department of Hematology, Amsterdam UMC, Vrije Universiteit, the Netherlands

Fredrik H. Schjesvold

3 Department of Hematology, Oslo Myeloma Center, Oslo University Hospital, Norway

Bronno van der Holt

5 Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands

Mark-David Levin

6 Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands

Maarten R. Seefat

1 Department of Hematology, Amsterdam UMC, Vrije Universiteit, the Netherlands

Markus Hansson

7 Department of Hematology, Skåne University Hospital Lund, Sweden

Maria B.L. Leys

8 Department of Internal Medicine, Maasstad Hospital, Rotterdam, the Netherlands

Josien C. Regelink

9 Department of Internal Medicine, Meander Medical Centre, Amersfoort, the Netherlands

Anders Waage

10 Institute of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Damian Szatkowski

11 Department of Oncology and Hematology, Førde Central Hospital, Norway

Per Axelsson

12 Department of Internal Medicine, Helsingborg Hospital, Sweden

Trung Hieu Do

13 Haematology Department H 60, Roskilde Sjaelland University, Denmark

Asta Svirskaite

14 Department of Hematology, Aalborg University Hospital, Denmark

Ellen van der Spek

15 Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands

Einar Haukas

16 Department for Blood and Cancer Diseases, Stavanger University Hospital, Norway

Dorota Knut-Bojanowska

17 Institute of Heamatology, Uddevalla Hospital, Sweden

Paula F. Ypma

18 Department of Hematology, Haga Hospital, The Hague, the Netherlands

Cecilie H. Blimark

19 Hematology Department, Sahlgrenska University Hospital, Gothenburg, Sweden

Ulf-Henrik Mellqvist

20 Department of Internal Medicine, Sodra Alvsborgs Sjukhus, Boras, Sweden

Niels W.C.J. van de Donk

1 Department of Hematology, Amsterdam UMC, Vrije Universiteit, the Netherlands

Pieter Sonneveld

21 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands

Anja Klostergaard

22 Department of Hematology, Aarhus University Hospital, Denmark

Annette J. Vangsted

23 Department of Hematology, Rigshospitalet, Copenhagen, Denmark

Niels Abildgaard

24 Department of Hematology, Hematology Research Unit and Academy of Geriatric Research, Odense University Hospital and University of Southern Denmark, Denmark

Sonja Zweegman

1 Department of Hematology, Amsterdam UMC, Vrije Universiteit, the Netherlands